Nearly 83.5% of all the orthopedic procedures performed in the US are estimated to be delayed, postponed or canceled due to COVID-19, as they are considered to be elective and non-essential, according to GlobalData, a leading data and analytics company.
GlobalData estimates only 16.5% of orthopedic procedures performed in the US are essential. The top essential procedures include traumas, amputations, and oncological procedures. Dislocations and fractures, including hip, pelvis, and forearms, should only be considered for treatment in urgent cases.”
Eric Chapman, Medical Devices Analyst at GlobalData
According to GlobalData, the elective procedures can be broadly segmented as fractures that are older than four weeks, chronic joint conditions, total joint replacements, and spinal fusions. The top ten procedures account for 62.5% of the total volume and include knee, hip, and shoulder replacements and spinal fusion procedures. These surgeries are being delayed during the COVID-19 crisis. While painful, outcomes will not be affected by delaying surgery.
The American Academy of Orthopedic Surgeons and American College of Surgeons recommend delaying elective surgeries to prevent the spread of COVID-19 and spare the use of beds, ventilators, and equipment. If possible, essential procedures and cases of anterior cruciate ligament tears, acute traumatic rotator cuff tears, femur or tibia fractures, and arthroscopy should be conducted in outpatient settings.
As many states have now passed peak numbers of COVID-19 cases, these guidelines are being modified to allow for the resumption of clinical activities and reopening facilities for elective surgery in multiple phases.
GlobalData estimates procedures such as total knee replacements to resume by mid-June when the number of new COVID-19 cases declines to around 0.75 per 100,000 of the population. It will likely take at least one year for procedure numbers to return to pre-COVID-19 levels. Medical centers should organize staff and resources to prepare for an influx of patients.”
Eric Chapman
Limited impact of prenatal COVID-19 exposure on child neurodevelopmental outcomes